Pharmaceutical-Biotech Construction Update: 31 New Facilities Open Doors in First Half of 2008

SUGAR LAND--July 15, 2008--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The first six months of 2008 have ended and within that time, the Pharmaceutical & Biotech Industry has completed construction on a total of 31 new plants and research centers across North America. The projects are a diverse group in terms of both size and focus, ranging from a $3.5 million 20,000-square-foot crime lab in Rockledge, Florida, to Amylin Pharmaceutical's (NASDAQ:AMLN) (San Diego, California) $80 million manufacturing plant addition in West Chester, Ohio. In Arkansas, the Alberto-Culver Company (NYSE: ACV) (Melrose Park, Illinois) completed construction at the beginning of the year on a $60 million personal care products production plant in Jonesboro. With six months left to go in 2008, the sector as a whole is expecting another 52 plants and laboratories to open before the year is over.